Clinical Trial Update: Intranasal Transmucosal Fentanyl Pectin for Breakthrough Cancer Pain in Radiation-induced Oropharyngeal Mucositis

View source ↗

Summary

A completed clinical trial (NCT02050503) evaluating intranasal transmucosal fentanyl pectin for breakthrough cancer pain in radiation-induced oropharyngeal muco…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Oropharyngeal Mucositis

Drugs mentioned

• Intranasal Transmucosal Fentanyl Pectin (fentanyl)

Snippet

Sponsor: Grupo de Investigación Clínica en Oncología Radioterapia | Conditions: Breakthrough Pain, Mucositis | Status: COMPLETED